Medical Rationale for Service-Based Medicine
See how choosing an injectable medication, as a valuable service your practice provides, helps patients and pet owners.
PRESENTER:
John C. Angus, DVM, DACVD
Animal Dermatology Clinic
Pasadena, California
What matters most when treating patients?
Keeping a medical mindset focused on two critical factors — and making recommendations accordingly.
What matters most when treating patients?
Service-based medicine provides value beyond the prescription
Noncompliance is only human
Q&A: What medical benefits do injectables provide that other therapies can't?
Q&A: Can using injectables help pet owners bond to my practice?
Key Points
Injectable medications offer many benefits:
- You can turn to them to safely provide rapid, effective treatment.
- Service-based medicine with injectables allows you to deliver an assured course of therapy that can improve pet health, is convenient for clients and brings added value to your practice.
- In-clinic administration ensures 100 percent compliance, which can be important for treatment success.
Harness the medical benefits of injectables with effective medications from our portfolio:
- CYTOPOINT® is an injectable monoclonal antibody that targets and neutralizes a specific cytokine that induces itch in canine allergic and atopic dermatitis. Learn more about this injectable »
- CONVENIA® (cefovecin sodium) is an injectable antibiotic for treating many common bacterial skin infections in dogs and cats. Learn more about this injectable »
- ProHeart®6 (moxidectin) is an injection for use in dogs 6 months of age or older to prevent heartworm disease for 6 months. Learn more about this injectable »
- ProHeart®12 (moxidectin) is an injection for use in dogs 12 months of age or older to prevent heartworm disease for one full year. Learn more about this injectable »
More Reasons to Use Injectable Medications
CYTOPOINT INDICATIONS: CYTOPOINT has been shown to be effective for the treatment of dogs against allergic dermatitis and atopic dermatitis.
CONVENIA INDICATION: Dogs: CONVENIA is indicated for the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).
Cats: CONVENIA is indicated for the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.
CONVENIA IMPORTANT SAFETY INFORMATION: People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to CONVENIA. Do not use in dogs or cats with a history of allergic reactions to penicillins or cephalosporins. Side effects for both dogs and cats include vomiting, diarrhea, decreased appetite/anorexia and lethargy. See full Prescribing Information.
PROHEART 6 INDICATIONS: ProHeart 6 is indicated for use in dogs six months of age and older for the prevention of heartworm disease caused by Dirofilaria immitis. ProHeart 6 is indicated for the treatment of existing larval and adult hookworm (Ancylostoma caninum and Uncinaria stenocephala) infections.
PROHEART 12 INDICATIONS: ProHeart 12 is indicated for use in dogs 12 months of age and older for the prevention of heartworm disease caused by Dirofilaria immitis for 12 months. ProHeart 12 is indicated for the treatment of existing larval and adult hookworm (Ancylostoma caninum and Uncinaria stenocephala) infections.
PROHEART 6 AND PROHEART 12 IMPORTANT SAFETY INFORMATION: Use PROHEART 6 in dogs 6 months of age or older and PROHEART 12 in dogs 12 months of age or older. Do not administer to dogs that are sick, debilitated, underweight, have a history of weight loss, or to those previously found to be hypersensitive to the drug. Hypersensitivity reactions may occur in some dogs when PROHEART is administered alone or with vaccines. Anaphylactic and anaphylactoid reactions can result in death and should be treated immediately with the same measures used to treat hypersensitivity reactions to vaccines and other injectable products. Reported side effects in clinical trials included vomiting, lethargy, diarrhea, anorexia, and hypersensitivity reactions. People should avoid inhalation, contact with eyes, or accidental self-injection. Certification is required before veterinarians and staff administer these products.
For more information, please see full Prescribing Information for PROHEART 6 and PROHEART 12.
United States 
